The GDH1 inhibitor R162, as a purpurin analog, is capable of reducing intracellular fumarate levels, attenuating GPx activity and disabling the AOD mechanism to suppress tumor cell proliferation 20, 21. This evidence concerns the gene GLUD1 and neoplasm.